SEC62 and neoplasm: In search of alternative mechanisms to inhibit Sec62 function, it was shown that treating tumor cells with the CaM antagonist TFP both in terms of migratory potential and cellular calcium homeostasis achieves the same phenotype as SEC62 silencing (Linxweiler et al., 2013) (Figure 4).